| Cancer and Skin Lesions | Lifetime | 11 | US 9 | 99.66 |
| Genetic and rare skin diseases. | Lifetime | 4 | US 4 | 99.67 |
| Medicine and Dermatology Studies History | Lifetime | 4 | US 2 | 99.38 |
| Cancer Diagnosis and Treatment | Lifetime | 47 | US 27 | 99.53 |
| Skin Diseases and Diabetes | Lifetime | 9 | US 6 | 99.45 |
| Dermatological and COVID-19 studies | Lifetime | 7 | US 5 | 99.19 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 30 | US 14 | 99.43 |
| Autoimmune Bullous Skin Diseases | Lifetime | 54 | US 22 | 99.29 |
| Nail Diseases and Treatments | Lifetime | 50 | US 27 | 99.34 |
| Vascular Malformations and Hemangiomas | Lifetime | 42 | US 27 | 98.67 |
| Oral Health Pathology and Treatment | Lifetime | 83 | US 29 | 99.02 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 83 | US 41 | 98.85 |
| Drug-Induced Adverse Reactions | Lifetime | 93 | US 27 | 98.22 |
| Autoimmune and Inflammatory Disorders | Lifetime | 72 | US 29 | 98.66 |
| Dermatological diseases and infestations | Lifetime | 43 | US 21 | 98.29 |
| Tumors and Oncological Cases | Lifetime | 143 | US 91 | 98.43 |
| Dermatological and Skeletal Disorders | Lifetime | 68 | US 35 | 98.31 |
| Genital Health and Disease | Lifetime | 160 | US 75 | 98.31 |
| Vascular Tumors and Angiosarcomas | Lifetime | 104 | US 48 | 98.35 |
| Eosinophilic Disorders and Syndromes | Lifetime | 208 | US 102 | 98.28 |
| Urticaria and Related Conditions | Lifetime | 204 | US 74 | 98.07 |
| melanin and skin pigmentation | Lifetime | 211 | US 89 | 97.68 |
| Skin and Cellular Biology Research | Lifetime | 176 | US 73 | 97.44 |
| Viral-associated cancers and disorders | Lifetime | 447 | US 210 | 97.58 |
| Cutaneous Melanoma Detection and Management | Lifetime | 300 | US 136 | 97.85 |
| Dermatologic Treatments and Research | Lifetime | 240 | US 113 | 97.49 |
| Histiocytic Disorders and Treatments | Lifetime | 104 | US 59 | 97.29 |
| Fungal Infections and Studies | Lifetime | 645 | US 244 | 96.22 |
| Tuberous Sclerosis Complex Research | Lifetime | 113 | US 69 | 94.74 |
| Hedgehog Signaling Pathway Studies | Lifetime | 427 | US 216 | 94.71 |
| Parvovirus B19 Infection Studies | Lifetime | 546 | US 252 | 94.84 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 397 | US 139 | 94.73 |
| Vasculitis and related conditions | Lifetime | 710 | US 184 | 94.18 |
| Acne and Rosacea Treatments and Effects | Lifetime | 354 | US 152 | 93.38 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 625 | US 259 | 93.28 |
| Neonatal skin health care | Lifetime | 73 | US 37 | 91.66 |
| Soft tissue tumors and treatment | Lifetime | 143 | US 69 | 91.98 |
| Chemotherapy-related skin toxicity | Lifetime | 435 | US 212 | 88.33 |
| Hair Growth and Disorders | Lifetime | 719 | US 257 | 88.55 |
| Dupuytren's Contracture and Treatments | Lifetime | 285 | US 115 | 85.46 |
| Bartonella species infections research | Lifetime | 302 | US 127 | 84.78 |
| Entomological Studies and Ecology | Lifetime | 993 | US 259 | 80.58 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 657 | US 239 | 67.79 |
| Tattoo and Body Piercing Complications | Lifetime | 333 | US 130 | 66.84 |
| Dermatological and COVID-19 studies | 2021-2025 | 43 | US 9 | 89.00 |
| Body Contouring and Surgery | 2021-2025 | 324 | US 133 | 81.45 |
| Bee Products Chemical Analysis | 2021-2025 | 822 | US 14 | 80.17 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 639 | US 195 | 79.67 |
| Genetic and rare skin diseases. | 2021-2025 | 143 | US 28 | 73.53 |
| Nail Diseases and Treatments | 2021-2025 | 748 | US 148 | 73.26 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 976 | US 361 | 70.55 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 829 | US 170 | 59.52 |
| Skin and Cellular Biology Research | 2021-2025 | 884 | US 190 | 49.87 |
| Skin Diseases and Diabetes | 2021-2025 | 508 | US 107 | 49.57 |
